Home LiteratureArticle Details
PMID: 18038118 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation.

Journal of biomedical science ·Vol. 15 ·No. 2 ·2008-03-00 ·Pages 163-8

Guo Z, Tsai MH, Shiao YH, Chen LH, Wei ML, Lv X, Gius D, Little JB, Mitchell JB, Chuang EY

Abstract

In cancer, gene silencing via hypermethylation is as common as genetic mutations in p53. Understanding the relationship between mutant p53 and hypermethylation of other tumor suppressor genes is essential when elucidate mechanisms of tumor development. In this study, two isogenic human B lymphoblast cell lines with different p53 status include TK6 containing wild-type p53 and WTK1 with mutant p53 were used and contrasted. Lower levels of p16(ink4A) protein were detected in WTK1 cells than in TK6 cells, which were accompanied by increased DNA (cytosine-5)-methyltransferase 1 (DNMT1) gene expression as well as hypermethylation of the p16 ( ink4A ) promoter. siRNA experiments to transiently knock down wild-type p53 in TK6 cells resulted in increase of DNMT1 expression as well as decrease of p16(ink4A) protein. Conversely, siRNA knockdown of mutant p53 in WTK1 cells did not alter either DNMT1 or p16(ink4A) protein levels. Furthermore, loss of suppression function of mutant p53 to DNMT1 in WTK1 was caused by the attenuation of its binding ability to the DNMT1 promoter. In summary, we provide evidences to elucidate the relationship between mutant p53 and DNMT1. Our results indicate that mutant p53 loses its ability to suppress DNMT1 expression, and thus enhances methylation levels of the p16 ( ink4A ) promoter and subsequently down-regulates p16(ink4A )protein.

MeSH Terms
B-Lymphocytes/metabolism Cell Line, Tumor Cyclin-Dependent Kinase Inhibitor p16/genetics,metabolism DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases/genetics,metabolism DNA Methylation Down-Regulation Humans Mutation Neoplasms/genetics,metabolism Promoter Regions, Genetic/genetics RNA, Small Interfering/genetics Tumor Suppressor Protein p53/antagonists & inhibitors,genetics,metabolism
Chemicals
Cyclin-Dependent Kinase Inhibitor p16 RNA, Small Interfering Tumor Suppressor Protein p53 DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases DNMT1 protein, human
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Guo Zhanjun
Radiation Biology and Oncology Branches, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Tsai Mong-Hsun
Shiao Yih-Horng
Chen Li-Han
Wei Mei-Ling
Lv Xing
Gius David
Little John B
Mitchell James B
Chuang Eric Y
Article Info
Journal
Journal of biomedical science
Abbr.
J Biomed Sci
ISSN
1423-0127
Published
2008-03-00
Epub
2007-00-24
Pages
163-8
Language
English
Region
England
NLM ID
9421567
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com